View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AT08 | Publication ID: Fall 2017 |
Title: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2019 (CMS-4182-P) | |
Abstract:
This proposed rule would set forth programmatic and operational changes to the Medicare Advantage (MA) and prescription drug benefit programs for contract year 2019. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Yes | Unfunded Mandates: No |
EO 13771 Designation: Deregulatory | |
CFR Citation: 42 CFR 417 42 CFR 422 42 CFR 423 42 CFR 483 ... (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: Pub. L. 114-198, sec. 702 Pub. L. 114-255, secs. 17005 & 17006 42 U.S.C. 1302 42 U.S.C. 1395hh |
Legal Deadline:
None |
||||||
Statement of Need: This rule is necessary to make revisions to the MA program (Part C) and Prescription Drug Benefit Program (Part D), and other changes to the regulations based on our continued experience in the administration of the Part C and Part D programs. |
||||||
Summary of the Legal Basis: This rule addresses multiple sections of the Social Security Act (including secs. 1102 and 1871) and the Public Health Service Act. It also implements section 704 of the Comprehensive Addiction and Recovery Act (CARA) and sections 17005 and 17006 of the 21 st Century Cures Act. |
||||||
Alternatives: This rule proposes approaches to improve the quality, accessibility and affordability of the Medicare Part C and Part D programs and to improve the CMS customer experience. The Agency will consider options that support these improvements. |
||||||
Anticipated Costs and Benefits: The rule includes changes that support innovative approaches by Medicare Advantage (MA) organizations and Part D sponsors in administering the benefit and that prevent improper provision of services, implementing changes in line with the Comprehensive Addiction and Recovery Act of 2016 and the 21st Century Cures Act. We believe the proposed changes will result in a reduction of burden to MA Organizations and Part D Sponsors and generate program savings. As we move toward publication, estimates of the cost and benefits of these provisions will be included in the rule. |
||||||
Risks: If this regulation is not published timely, changes will not be in place for contract year 2019. |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
Small Entities Affected: Businesses, Governmental Jurisdictions, Organizations | Federalism: No |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: No | |
Agency Contact: Christian Bauer Director, Division of Part D Policy Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C1-26-16, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-6043 Email: christian.bauer@cms.hhs.gov |